{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:32:30Z","timestamp":1781109150335,"version":"3.54.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,7]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>There are many causes of hypercalcemia, with hyperparathyroidism and malignancy accounting for 90% of cases. Sarcoidosis and the intake of vitamin D supplements may also cause hypercalcemia, although the occurrence rate is low if only one is involved. We herein report a sarcoidosis patient who developed hypercalcemia after taking cholecalciferol (vitamin D supplement) for a year.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concern:<\/jats:title>\n            <jats:p>A 62-year-old Japanese man presented with hypercalcemia and acute kidney injury along with symptoms of fatigue and appetite loss while being followed up for sarcoidosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>We determined that a combination of cholecalciferol supplementation and sarcoidosis had led to hypercalcemia for several reasons. First, hypercalcemia had not been noted when this patient had first been admitted due to sarcoidosis-related respiratory failure several years earlier, which we presumed that was the highest sarcoidosis disease activity. Second, low serum 25-OH Vit.D<jats:sub>3<\/jats:sub> and high 1,25-(OH)<jats:sub>2<\/jats:sub> Vit.D<jats:sub>3<\/jats:sub> levels were noted despite cholecalciferol supplementation for a year, suggesting that 1-\u03b1-hydroxylase overexpression caused by sarcoidosis accelerated the conversion from 25-OH Vit.D<jats:sub>3<\/jats:sub> to 1,25-(OH)<jats:sub>2<\/jats:sub> Vit.D<jats:sub>3<\/jats:sub>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Although initially resistant to preservative management, the hypercalcemia promptly improved after starting corticosteroid treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Hypercalcemia and acute kidney injury were normalized after corticosteroid treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We should be aware of patients\u2019 medications, especially in patients with granulomatosis disease. The concomitant measurement of 25-OH Vit.D<jats:sub>3<\/jats:sub> and 1,25-(OH)<jats:sub>2<\/jats:sub> Vit.D<jats:sub>3<\/jats:sub> levels is useful for determining the cause of hypercalcemia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000030883","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T14:50:53Z","timestamp":1665413453000},"page":"e30883","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Hypercalcemia worsened after vitamin D supplementation in a sarcoidosis patient: A case report"],"prefix":"10.1097","volume":"101","author":[{"given":"Kimito","family":"Mio","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-0390","authenticated-orcid":false,"given":"Kotaro","family":"Haruhara","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Oshiro","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Kawai","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 17","key":"R1-20250504","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1681\/ASN.V12suppl_1s3","article-title":"Hypercalcemic crisis.","volume":"12","author":"Ziegler","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R2-20250504","first-page":"71","article-title":"Hypercalcemia: an evidence-based approach to clinical cases.","volume":"3","author":"Assadi","year":"2009","journal-title":"Iran J Kidney Dis"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/jbmr.5650061413","article-title":"Differential diagnosis of hypercalcemia.","volume":"6 Suppl 2","author":"Lafferty","year":"1991","journal-title":"J Bone Miner Res"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(63)90055-X","article-title":"Seasonal influence of sunlight on the hypercalcemia of sarcoidosis.","volume":"34","author":"Taylor","year":"1963","journal-title":"Am J Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/thx.53.5.425","article-title":"Clinical impact of bone and calcium metabolism changes in sarcoidosis.","volume":"53","author":"Rizzato","year":"1998","journal-title":"Thorax"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jsbmb.2018.12.010","article-title":"Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: insights from a seven year experience.","volume":"189","author":"McCullough","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"12 Pt 1","key":"R7-20250504","first-page":"5624","article-title":"Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.","volume":"44","author":"Koeffler","year":"1984","journal-title":"Cancer Res"},{"key":"R8-20250504","first-page":"888","article-title":"Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.","volume":"86","author":"Zehnder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/07315724.2009.10719779","article-title":"Vitamin D3 distribution and status in the body.","volume":"28","author":"Heaney","year":"2009","journal-title":"J Am Coll Nutr"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsbmb.2017.11.014","article-title":"Why should we measure free 25(OH) vitamin D?","volume":"180","author":"Tsuprykov","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0002-9343(01)00724-0","article-title":"Correlation between 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis.","volume":"110","author":"Inui","year":"2001","journal-title":"Am J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:39:39Z","timestamp":1746333579000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":11,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030883","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}